TickerFacts.

Evofem Biosciences, Inc. (EVFM): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$17.37M
Year ended 2023-12-31
2013-12-31: -$14.35M2014-12-31: -$9.57M2015-12-31: -$41.99M2016-12-31: -$11.97M2017-12-31: -$35.44M2018-12-31: -$77.38M2019-12-31: -$52.48M2020-12-31: -$103.32M2021-12-31: -$165.78M2022-12-31: -$83.11M2023-12-31: -$17.37M-$17.37M
2013-12-31 EBITDA (USD) 2023-12-31
Period endedEBITDAChange YoYSource filing
2023-12-31-$17.37Mn/m2025-03-24, From 2023-01-01
2022-12-31-$83.11Mn/m2024-03-27, From 2022-01-01
2021-12-31-$165.78Mn/m2023-04-27, From 2021-01-01
2020-12-31-$103.32Mn/m2022-03-10, From 2020-01-01
2019-12-31-$52.48Mn/m2021-03-04, From 2019-01-01
2018-12-31-$77.38Mn/m2020-03-12, From 2018-01-01
2017-12-31-$35.44Mn/m2019-03-01, From 2017-01-01
2016-12-31-$11.97Mn/m2018-02-26, From 2016-01-01
2015-12-31-$41.99Mn/m2018-02-26, From 2015-01-01
2014-12-31-$9.57Mn/m2017-03-23, From 2014-01-01
2013-12-31-$14.35Mn/a2016-03-29, From 2013-01-01